日本語 ／ English
Japan Healthcare Venture Summit 2023
Announcement on Completion of signing additional license agreement with Takeda Pharmaceutical Co., Ltd.
Representative Director/CEO Mr.Toriya gave a lecture at the Symposium of the 143rd Annual Meeting of the Pharmaceutical Society of Japan on March 28, 2023
Announcement on Completion of signing license agreement with NIPPON SHOKUBAI Co., Ltd..
Announcement on Completion of signing license agreement with Nippon Gene Material Co., Ltd.
Japan Healthcare Venture Summit 2022
Notice of publication in the Nikkan Kogyo Shimbun
Notice of publication in Nikkei Biotechnology
Notice of publication in the magazine "NEW LEADER"
Announcement of selection for an AMED drug discovery basic technology project for the realization of next-generation treatment and diagnosis entitled “Innovative Next Generation of Oligonucleotide Therapeutics (INGOT)”
Japan Healthcare Venture Summit 2021